QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress quietly expands corporate tax breaks, shifting burden to wage earners

H.R. 3967 — CREATE JOBS Act · Filed by Glenn Grothman (R-WI) · 3 cosponsors · Introduced Jun 12, 2025 · Referred to committee

25%
Transparency
Typical bill: 82%
35/100
Hidden-provision risk
Typical bill: 15/100
High concernCorporate Tax Expenditure Acceleration

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill makes three major changes to business tax law: (1) it allows companies to immediately deduct 100% of the cost of equipment and property purchases instead of depreciating them over years; (2) it adjusts depreciation deductions for real estate based on inflation using a complex GDP deflator formula; and (3) it eliminates the requirement that research and development costs be amortized over time, allowing immediate expensing instead. The primary beneficiaries are corporations and businesses with significant capital investments and R&D spending.

Why we flagged it

The bill's core function is to accelerate and expand business tax deductions—allowing immediate expensing of capital and R&D costs rather than spreading them over time. This reduces taxable income for corporations and capital-intensive businesses, functioning as a targeted tax expenditure benefiting private enterprise.

What the text implies

  • The 'neutral cost recovery ratio' formula tied to GDP deflators creates a mechanism that automatically increases real estate depreciation deductions as inflation rises, effectively indexing tax benefits to inflation in a way that benefits property owners disproportionately.
  • Elimination of R&D amortization requirements means companies can claim full deductions immediately rather than over time, front-loading tax savings and reducing present-value tax liability compared to prior law.

The full analysis lists 4 implications of this text.

Who stands to gain

capital-intensive manufacturers; real estate investment trusts (REITs); technology and pharmaceutical companies with high R&D spending

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record